{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:59:55Z","timestamp":1791500395108,"version":"4.3.4"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,2]]},"DOI":"10.1093\/jnci\/djn188","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T02:58:48Z","timestamp":1214362728000},"page":"926-939","source":"Crossref","is-referenced-by-count":133,"title":["Association Between Imatinib-Resistant BCR-ABL Mutation-Negative Leukemia and Persistent Activation of LYN Kinase"],"prefix":"10.1093","volume":"100","author":[{"given":"Ji","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunming","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Bornmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant G.","family":"Darnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Lamothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Talpaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,2]]},"reference":[{"issue":"15","key":"key\n\t\t\t\t20170702074337_bib1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2014advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"key\n\t\t\t\t20170702074337_bib2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"issue":"10","key":"key\n\t\t\t\t20170702074337_bib3","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","article-title":"Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study","volume":"99","author":"Sawyers","year":"2002","journal-title":"Blood"},{"issue":"10","key":"key\n\t\t\t\t20170702074337_bib4","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood.V99.10.3547","article-title":"Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase","volume":"99","author":"Kantarjian","year":"2002","journal-title":"Blood"},{"issue":"5531","key":"key\n\t\t\t\t20170702074337_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"issue":"1","key":"key\n\t\t\t\t20170702074337_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis","volume":"102","author":"Branford","year":"2003","journal-title":"Blood"},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell."},{"issue":"9305","key":"key\n\t\t\t\t20170702074337_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(02)07679-1","article-title":"BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study","volume":"359","author":"von Bubnoff","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood-2005-11-4687","article-title":"OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib","volume":"108","author":"White","year":"2006","journal-title":"Blood"},{"issue":"20","key":"key\n\t\t\t\t20170702074337_bib10","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/jnci\/92.20.1641","article-title":"Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571","volume":"92","author":"Gambacorti-Passerini","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.V99.2.713","article-title":"Alpha1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571","volume":"99","author":"Jorgensen","year":"2002","journal-title":"Blood"},{"issue":"11","key":"key\n\t\t\t\t20170702074337_bib12","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"issue":"8","key":"key\n\t\t\t\t20170702074337_bib13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/cncr.20922","article-title":"Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up","volume":"103","author":"Lahaye","year":"2005","journal-title":"Cancer"},{"issue":"12","key":"key\n\t\t\t\t20170702074337_bib14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.4161\/cc.4.12.2261","article-title":"BCR-ABL kinase domain mutations in chronic myeloid leukemia: not quite enough to cause resistance to imatinib therapy?","volume":"4","author":"Lange","year":"2005","journal-title":"Cell Cycle"},{"issue":"4","key":"key\n\t\t\t\t20170702074337_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.leu.2404137","article-title":"The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib","volume":"20","author":"Khorashad","year":"2006","journal-title":"Leukemia"},{"issue":"12","key":"key\n\t\t\t\t20170702074337_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00277-006-0171-8","article-title":"Not all imatinib resistance in CML are BCR-ABL kinase domain mutations","volume":"85","author":"Wei","year":"2006","journal-title":"Ann Hematol"},{"issue":"8","key":"key\n\t\t\t\t20170702074337_bib17","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"key\n\t\t\t\t20170702074337_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2005.10.015","article-title":"The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR\/ABL-regulated SET protein","volume":"8","author":"Neviani","year":"2005","journal-title":"Cancer Cell"},{"issue":"11","key":"key\n\t\t\t\t20170702074337_bib19","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1073\/pnas.0604716104","article-title":"Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment","volume":"104","author":"Miething","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"key\n\t\t\t\t20170702074337_bib20","first-page":"3589","article-title":"Activation of Src kinases p53\/56Lyn and p59hck by p210bcr\/abl in myeloid cells","volume":"56","author":"Danhauser-Riedl","year":"1996","journal-title":"Cancer Res."},{"issue":"6","key":"key\n\t\t\t\t20170702074337_bib21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.leu.2401429","article-title":"Therapeutic targeting of Src-kinase Lyn in myeloid leukemic cell growth","volume":"13","author":"Roginskaya","year":"1999","journal-title":"Leukemia"},{"issue":"5","key":"key\n\t\t\t\t20170702074337_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia","volume":"36","author":"Hu","year":"2004","journal-title":"Nat Genet."},{"issue":"53","key":"key\n\t\t\t\t20170702074337_bib23","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1038\/sj.onc.1206008","article-title":"Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis","volume":"21","author":"Wilson","year":"2002","journal-title":"Oncogene"},{"issue":"21","key":"key\n\t\t\t\t20170702074337_bib24","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1093\/emboj\/cdf562","article-title":"The Src family kinase Hck couples BCR\/ABL to STAT5 activation in myeloid leukemia cells","volume":"21","author":"Klejman","year":"2002","journal-title":"EMBO J"},{"issue":"24","key":"key\n\t\t\t\t20170702074337_bib25","doi-asserted-by":"crossref","first-page":"18581","DOI":"10.1074\/jbc.C000126200","article-title":"Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck","volume":"275","author":"Lionberger","year":"2000","journal-title":"J Biol Chem."},{"issue":"52","key":"key\n\t\t\t\t20170702074337_bib26","doi-asserted-by":"crossref","first-page":"33260","DOI":"10.1074\/jbc.272.52.33260","article-title":"The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr","volume":"272","author":"Warmuth","year":"1997","journal-title":"J Biol Chem."},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.leu.2402778","article-title":"The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains","volume":"17","author":"Stanglmaier","year":"2003","journal-title":"Leukemia"},{"issue":"9","key":"key\n\t\t\t\t20170702074337_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/sj.leu.2403040","article-title":"Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo","volume":"17","author":"Miething","year":"2003","journal-title":"Leukemia"},{"issue":"41","key":"key\n\t\t\t\t20170702074337_bib29","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1074\/jbc.M605902200","article-title":"Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity","volume":"281","author":"Meyn","year":"2006","journal-title":"J Biol Chem."},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-03-1484","article-title":"Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia","volume":"64","author":"Donato","year":"2004","journal-title":"Cancer Res."},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.V101.2.690","article-title":"BCR-ABL independence and Lyn kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571","volume":"101","author":"Donato","year":"2003","journal-title":"Blood"},{"issue":"33","key":"key\n\t\t\t\t20170702074337_bib32","doi-asserted-by":"crossref","first-page":"34227","DOI":"10.1074\/jbc.M402290200","article-title":"A Bcr\/Abl-independent Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2","volume":"279","author":"Dai","year":"2004","journal-title":"J Biol Chem."},{"issue":"5","key":"key\n\t\t\t\t20170702074337_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.2007.00835.x","article-title":"Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn","volume":"78","author":"Ito","year":"2007","journal-title":"Eur J Haematol"},{"issue":"45","key":"key\n\t\t\t\t20170702074337_bib34","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice","volume":"103","author":"Hu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"key\n\t\t\t\t20170702074337_bib35","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","article-title":"Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics","volume":"31","author":"Kitamura","year":"2003","journal-title":"Exp Hematol"},{"issue":"6","key":"key\n\t\t\t\t20170702074337_bib36","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1074\/jbc.M608867200","article-title":"TAK1-dependent signaling requires functional interaction with TAB2\/TAB3","volume":"282","author":"Besse","year":"2007","journal-title":"J Biol Chem."},{"issue":"5486","key":"key\n\t\t\t\t20170702074337_bib37","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of abelson tyrosine kinase","volume":"289","author":"Schindler","year":"2000","journal-title":"Science"},{"issue":"1","key":"key\n\t\t\t\t20170702074337_bib38","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative","volume":"56","author":"Buchdunger","year":"1996","journal-title":"Cancer Res."},{"issue":"5682","key":"key\n\t\t\t\t20170702074337_bib39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"issue":"24","key":"key\n\t\t\t\t20170702074337_bib40","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20170702074337_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","article-title":"Mechanisms of autoinhibition and STI-571\/imatinib resistance revealed by mutagenesis of BCR-ABL","volume":"112","author":"Azam","year":"2003","journal-title":"Cell."},{"issue":"11","key":"key\n\t\t\t\t20170702074337_bib42","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm1127","article-title":"Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells","volume":"10","author":"Ptasznik","year":"2004","journal-title":"Nat Med"},{"issue":"9","key":"key\n\t\t\t\t20170702074337_bib43","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1073\/pnas.0409770102","article-title":"Comparative analysis of two clinically active BCR-ABL kinase inhibitors reveals the role of conformation-specific binding in resistance","volume":"102","author":"Burgess","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1-3","key":"key\n\t\t\t\t20170702074337_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0014-5793(03)00404-6","article-title":"Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215","volume":"543","author":"Vadlamudi","year":"2003","journal-title":"FEBS Lett."},{"issue":"8","key":"key\n\t\t\t\t20170702074337_bib45","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ncponc0558","article-title":"Mechanisms of disease: oncogene addiction\u2014a rationale for molecular targeting in cancer therapy","volume":"3","author":"Weinstein","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170702074337_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2006.09.014","article-title":"A common signaling cascade may underlie \u201caddiction\u201d to the Src, BCR-ABL, and EGF receptor oncogenes","volume":"10","author":"Sharma","year":"2006","journal-title":"Cancer Cell."},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/08977190600581327","article-title":"The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling","volume":"24","author":"Hibbs","year":"2006","journal-title":"Growth Factors"},{"issue":"35","key":"key\n\t\t\t\t20170702074337_bib48","doi-asserted-by":"crossref","first-page":"36259","DOI":"10.1074\/jbc.M402469200","article-title":"Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation","volume":"279","author":"Kaabeche","year":"2004","journal-title":"J Biol Chem."},{"issue":"2","key":"key\n\t\t\t\t20170702074337_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/blood-2006-07-035493","article-title":"Dasatinib (BMS-354825) is active in Philadelphia chromosome-positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure","volume":"109","author":"Quintas-Cardama","year":"2007","journal-title":"Blood"},{"issue":"6","key":"key\n\t\t\t\t20170702074337_bib50","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1182\/blood-2006-09-047266","article-title":"Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy","volume":"109","author":"Hochhaus","year":"2007","journal-title":"Blood"},{"issue":"8","key":"key\n\t\t\t\t20170702074337_bib51","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1182\/blood-2006-09-046888","article-title":"Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis","volume":"109","author":"Cortes","year":"2007","journal-title":"Blood"},{"issue":"1","key":"key\n\t\t\t\t20170702074337_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.exphem.2003.09.018","article-title":"Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl","volume":"32","author":"Gaston","year":"2004","journal-title":"Exp Hematol"},{"issue":"26","key":"key\n\t\t\t\t20170702074337_bib53","doi-asserted-by":"crossref","first-page":"16170","DOI":"10.1074\/jbc.272.26.16170","article-title":"Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells","volume":"272","author":"Bhat","year":"1997","journal-title":"J Biol Chem."},{"issue":"24","key":"key\n\t\t\t\t20170702074337_bib54","doi-asserted-by":"crossref","first-page":"14347","DOI":"10.1074\/jbc.270.24.14347","article-title":"Tyrosine phosphorylation and translocation of the c-cbl protein after activation of tyrosine kinase signaling pathways","volume":"270","author":"Tanaka","year":"1995","journal-title":"J Biol Chem."},{"issue":"1","key":"key\n\t\t\t\t20170702074337_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.onc.1203254","article-title":"Involvement of Shc and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF","volume":"19","author":"Grishin","year":"2000","journal-title":"Oncogene"},{"issue":"12","key":"key\n\t\t\t\t20170702074337_bib56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/gcc.20377","article-title":"Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2","volume":"45","author":"Patel","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"key\n\t\t\t\t20170702074337_bib57","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","article-title":"In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants","volume":"65","author":"O'Hare","year":"2005","journal-title":"Cancer Res."}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/100\/13\/926\/18074485\/djn188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:11:24Z","timestamp":1503573084000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djn188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,2]]},"references-count":57,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2008,7,2]]},"published-print":{"date-parts":[[2008,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djn188","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,2]]}}}